Industry Conference

With Intel's new Panther Lake chips, ARBOR Technology is moving AI model training from the cloud to the device, promising a new era of truly adaptive automation.

New Phase 3 data for Takeda's oveporexton shows it treats the root cause of narcolepsy, not just symptoms. A key FDA decision looms this year.

As the powersports industry faces a crippling technician shortage, Yamaha stands alone, betting on youth education to secure its future and its dealer network.

As autonomous AI agents begin to dominate internet traffic, a new cybersecurity battleground is emerging. We explore the shift to agent trust management.

At VivaTech 2026, JCDecaux unveiled a bus shelter that fights heatwaves and AI-driven ads, blurring the line between public service and modern commerce.

As AI promises to revolutionize medicine, enterprises face complex challenges. A new ISG study aims to chart the critical partner ecosystem.

A defense tech investor's bet on a Databricks partner reveals a crucial truth: the AI revolution will be built not by algorithms alone, but by modernizing data.

New data reveals a startling truth: confusing parking payments aren't just annoying—they're costing local businesses and reshaping how we live in our cities.

A small-town medical spa is investing in cutting-edge tech for body, bladder, and brain. Is this the future of healthcare or a high-stakes gamble?

Chicago's Automate 2026 isn't just a tech show. It's a critical look at how AI and robotics are solving today's business crises and shaping future profits.

Novarc's Physical AI is joining forces with Yaskawa's robotic muscle, promising to bring true autonomy and intelligence to the factory floor. Here's why.

xSuite's deep SAP integration and advanced AI earned it a 'Strong Performer' rank in Forrester's 2026 AP automation report, praised for high accuracy.

A landmark conference aims to train 500 youth, uniting regulators, industry giants, and top universities to build Maryland's digital asset future.

A new precision drug, ART5803, is offering hope for a devastating brain disorder. Arialys Therapeutics is fast-tracking its development with key clinical trials.

New data reveals upstream patient guidance slashes surgical costs, challenging the old guard of healthcare management and signaling a new era of digital-first care.

As AI-powered identity attacks render traditional MFA obsolete, a new partnership leverages the secure hardware already in your phone to offer a phishing-proof future.

Sumitomo Pharma's new data reveals a potent combination therapy for myelofibrosis and decodes resistance in leukemia, shaking up a competitive oncology landscape.

For 11 years, CBTS has made CRN's elite list. We unpack how their full-stack strategy and focus on AI are redefining resilience for modern enterprises.

In the competitive eCommerce landscape, Arizona businesses are leveraging strategic inventory placement to overcome regional challenges and win the last mile.

Visa and Rockefeller Center's new partnership is more than perks. It's a calculated play for the future of tourism, brand loyalty, and data-driven strategy.